Class information for:
Level 1: BELAGENPUMATUCEL L//SRL172//PA MSHA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23594 286 47.8 85%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BELAGENPUMATUCEL L Author keyword 12 86% 2% 6
2 SRL172 Author keyword 6 71% 2% 5
3 PA MSHA Author keyword 4 75% 1% 3
4 HTERTC27 Author keyword 4 56% 2% 5
5 L BLP25 Author keyword 2 36% 2% 5
6 ABT ONKOL HAMATOL IMMUNOL RHEUMATOL PULMOL 2 Address 2 67% 1% 2
7 PA MSHA VACCINE Author keyword 2 67% 1% 2
8 CIMAVAX Author keyword 1 100% 1% 2
9 GV1001 Author keyword 1 50% 1% 2
10 IMMUNITE CELLULAIRE ANTIVIRALE Address 1 50% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 BELAGENPUMATUCEL L 12 86% 2% 6 Search BELAGENPUMATUCEL+L Search BELAGENPUMATUCEL+L
2 SRL172 6 71% 2% 5 Search SRL172 Search SRL172
3 PA MSHA 4 75% 1% 3 Search PA+MSHA Search PA+MSHA
4 HTERTC27 4 56% 2% 5 Search HTERTC27 Search HTERTC27
5 L BLP25 2 36% 2% 5 Search L+BLP25 Search L+BLP25
6 PA MSHA VACCINE 2 67% 1% 2 Search PA+MSHA+VACCINE Search PA+MSHA+VACCINE
7 CIMAVAX 1 100% 1% 2 Search CIMAVAX Search CIMAVAX
8 GV1001 1 50% 1% 2 Search GV1001 Search GV1001
9 C3BGP 1 40% 1% 2 Search C3BGP Search C3BGP
10 RACOTUMOMAB 1 40% 1% 2 Search RACOTUMOMAB Search RACOTUMOMAB

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 REVERSE TRANSCRIPTASE PEPTIDE 14 100% 2% 7
2 BLP25 LIPOSOME VACCINE 10 42% 7% 19
3 BELAGENPUMATUCEL L 9 64% 3% 9
4 MYCOBACTERIUM VACCAE 5 25% 6% 16
5 ORAL TALACTOFERRIN 3 39% 2% 7
6 GROWTH FACTOR VACCINE 3 100% 1% 3
7 HUMAN HEPARANASE 3 60% 1% 3
8 SRL172 2 67% 1% 2
9 SRL172 MYCOBACTERIUM VACCAE 2 50% 1% 3
10 TRANSFECTED DENDRITIC CELLS 1 11% 4% 12

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Beyond the Standard of Care: A Review of Novel Immunotherapy Trials for the Treatment of Lung Cancer 2013 19 44 25%
Telomerase in cancer immunotherapy 2010 35 77 39%
Vaccination therapy for non-small-cell lung cancer: review of agents in phase III development 2012 24 39 26%
Vaccination therapy for non-small-cell lung cancer 2014 9 23 30%
Epidermal growth factor vaccine in non-small-cell lung cancer 2012 4 17 65%
hTERT-based therapy: A universal anticancer approach (Review) 2012 7 49 33%
Prospects and challenges of building a cancer vaccine targeting telomerase 2008 19 84 36%
Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer 2013 4 36 28%
Immunotherapy for lung cancer: ongoing clinical trials 2014 10 61 15%
Immunotherapy and lung cancer: current developments and novel targeted therapies 2014 3 56 25%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ABT ONKOL HAMATOL IMMUNOL RHEUMATOL PULMOL 2 2 67% 0.7% 2
2 IMMUNITE CELLULAIRE ANTIVIRALE 1 50% 0.7% 2
3 ST JAMES WING LEVEL 3 1 100% 0.7% 2
4 UNITE VIROL MOL VECTOROL 1 100% 0.7% 2
5 VAXON BIOTECH 1 100% 0.7% 2
6 GASTROENTEROL PLA 1 40% 0.7% 2
7 REG LUNG DIS 1 33% 0.7% 2
8 BIOCHIM STRUCTUMR 554 1 50% 0.3% 1
9 CANC IMMUNOTHER EUT 1 50% 0.3% 1
10 HAVANA 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000204510 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
2 0.0000180064 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN
3 0.0000166067 CANCER TESTIS ANTIGEN//CANCER TESTIS ANTIGENS//NY ESO 1
4 0.0000124083 ANTIANGIOGENIC CANCER VACCINE//CELL PROTEOMIC FOOTPRINTING//HER1 VACCINE
5 0.0000117716 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
6 0.0000112870 CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS
7 0.0000108943 NEUGCGM3//N GLYCOLYL GM3//CMP N ACETYLNEURAMINIC ACID HYDROXYLASE
8 0.0000108476 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE
9 0.0000102484 TELOMERASE//HTERT//TELOMERASE ACTIVITY
10 0.0000091141 CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CYTOKINE INDUCED KILLER CELL